MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tenax Therapeutics (TENX) Ownership - Who owns Tenax Therapeutics?
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.65M
P/E Ratio
3.37
Total Cash
111.45M
Projected Growth
N/A
Total Debt
413.17K
Revenue
N/A
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash/Share
26.86
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TENX
Capitalization
23.6M
P/E Ratio
3.37
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash
111M
Total Cash/Share
26.86
Total Debt
413K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
109M
P/B Ratio
0.22
Cash Flow
N/A
Earnings
1.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
40.48
Current Revenue Per Employee
4107.17
Dividends Per Share - Security
N/A
EBITDA
-24.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-38.27
Shares Held By Institutions
13.5M
Shares Outstanding - Current
4.15M
Total Liabilities
2.77M
Total Volume MTD
N/A
Value
1
Gain YTD
-7.916
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com